BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9714521)

  • 21. Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis.
    Oltmanns U; Schmidt B; Hoernig S; Witt C; John M
    Exp Lung Res; 2003 Jul; 29(5):315-28. PubMed ID: 12746045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive and modulated cytokine expression in two permanent human bone marrow stromal cell lines.
    Thalmeier K; Meissner P; Reisbach G; Hültner L; Mortensen BT; Brechtel A; Oostendorp RA; Dörmer P
    Exp Hematol; 1996 Jan; 24(1):1-10. PubMed ID: 8536785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early cytokine and chemokine gene expression during Pseudomonas aeruginosa corneal infection in mice.
    Kernacki KA; Goebel DJ; Poosch MS; Hazlett LD
    Infect Immun; 1998 Jan; 66(1):376-9. PubMed ID: 9423885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
    Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM
    Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MIP-1alpha and TGF-beta production in CD34+ progenitor-stromal cell coculture systems: effects of progenitor isolation method and cell-cell contact.
    Liesveld JL; Harbol AW; Belanger T; Rosell KE; Abboud CN
    Blood Cells Mol Dis; 2000 Aug; 26(4):261-75. PubMed ID: 11042027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium.
    De Bruyn C; Delforge A; Bron D; Ley P; de Hemptinne D; Stryckmans P
    Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production and pre-clinical significance of haematopoietic peptide growth factors (HPGF) in human non-seminomatous germ cell tumour cell lines.
    Dunn TA; Schmoll HJ; Rie C; Hartmann K; Casper J
    J Cancer Res Clin Oncol; 1998; 124(8):435-43. PubMed ID: 9750020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantation.
    Nagler A; Shur I; Barak V; Fabian I
    Leuk Res; 1996 Aug; 20(8):637-43. PubMed ID: 8913316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients.
    Wallace SR; Oken MM; Lunetta KL; Panoskaltsis-Mortari A; Masellis AM
    Cancer; 2001 Apr; 91(7):1219-30. PubMed ID: 11283920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine production in long-term marrow cultures after autologous bone marrow transplantation.
    Roingeard F; Domenech J; Dayan A; Gihana E; Colombat P; Binet C
    Bone Marrow Transplant; 1995 May; 15(5):741-7. PubMed ID: 7545488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial.
    Vose JM; Pandite AN; Beveridge RA; Geller RB; Schuster MW; Anderson JE; LeMaistre CF; Ahmed T; Granena A; Keating A; Fernandez Ranada JM; Stiff PJ; Tabbara I; Longo W; Copelan EA; Nichols C; Smith A; Topolsky DL; Bierman PJ; Lebsack ME; Lange M; Garrison L
    J Clin Oncol; 1997 Apr; 15(4):1617-23. PubMed ID: 9193361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow stroma damage induced by chemotherapy for acute lymphoblastic leukemia in children.
    Corazza F; Hermans C; Ferster A; Fondu P; Demulder A; Sariban E
    Pediatr Res; 2004 Jan; 55(1):152-8. PubMed ID: 14561785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candida albicans can stimulate stromal cells resulting in enhanced granulopoiesis.
    Basu S; Zhang HH; Quilici C; Dunn AR
    Stem Cells Dev; 2004 Feb; 13(1):39-50. PubMed ID: 15068692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages.
    Majumdar MK; Thiede MA; Haynesworth SE; Bruder SP; Gerson SL
    J Hematother Stem Cell Res; 2000 Dec; 9(6):841-8. PubMed ID: 11177595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
    Lemoli RM; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
    Acta Haematol; 1996; 95(3-4):164-70. PubMed ID: 8677737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombopoietin and chemokine mRNA expression in patient post-chemotherapy and in vitro cytokine-treated marrow stromal cell layers.
    Schwartz GN; Kammula U; Warren MK; Park MK; Yan XY; Marincola FM; Gress RE
    Stem Cells; 2000; 18(5):331-42. PubMed ID: 11007917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A murine stromal cell line promotes the proliferation of the human factor-dependent leukemic cell line UT-7.
    Auffray I; Dubart A; Izac B; Vainchenker W; Coulombel L
    Exp Hematol; 1994 May; 22(5):417-24. PubMed ID: 7513651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A secreted and LIF-mediated stromal cell-derived activity that promotes ex vivo expansion of human hematopoietic stem cells.
    Shih CC; Hu MC; Hu J; Weng Y; Yazaki PJ; Medeiros J; Forman SJ
    Blood; 2000 Mar; 95(6):1957-66. PubMed ID: 10706861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
    Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
    Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.